Ventas Inc
$ 82.02
3.69%
05 Jun - close price
- Market Cap 39,875,641,000 USD
- Current Price $ 82.02
- High / Low $ 82.95 / 78.78
- Stock P/E 149.13
- Book Value 27.00
- EPS 0.55
- Next Earning Report 2026-07-29
- Dividend Per Share $1.96
- Dividend Yield 2.48 %
- Next Dividend Date 2026-07-16
- ROA 0.02 %
- ROE 0.02 %
- 52 Week High 91.06
- 52 Week Low 60.57
About
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.
Analyst Target Price
$96.80
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-27 | 2026-02-05 | 2025-10-29 | 2025-07-30 | 2025-04-30 | 2025-02-12 | 2024-10-30 | 2024-08-01 | 2024-05-01 | 2024-02-14 | 2023-11-02 | 2023-08-03 |
| Reported EPS | 0.1 | 0.13 | 0.14 | 0.15 | 0.1 | 0.13 | 0.05 | 0.02 | -0.03 | -0.3 | -0.18 | 0.28 |
| Estimated EPS | 0.1 | 0.09 | 0.09 | 0.14 | 0.07 | 0.05 | -0.02 | 0.01 | -0.38 | -0.17 | -0.01 | 0.03 |
| Surprise | 0 | 0.04 | 0.05 | 0.01 | 0.03 | 0.08 | 0.07 | 0.01 | 0.35 | -0.13 | -0.17 | 0.25 |
| Surprise Percentage | 0% | 44.4444% | 55.5556% | 7.1429% | 42.8571% | 160% | 350% | 100% | 92.1053% | -76.4706% | -1700% | 833.3333% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.96 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-16 | 2026-01-15 | 2025-10-16 | 2025-07-17 | 2025-04-17 | 2025-01-16 | 2024-10-17 | 2024-07-18 | 2024-04-18 | 2024-01-18 |
| Amount | $0.52 | $0.48 | $0.48 | $0.48 | $0.48 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 |
Next Dividend Records
| Dividend per share (year): | $1.96 |
| Dividend Yield | 2.48% |
| Next Dividend Date | 2026-07-16 |
| Ex-Dividend Date | 2026-06-30 |
Recent News: VTR
2026-06-05 21:21:37
Ventas (VTR) shares rose 5.4% after the company provided an upbeat senior-housing update and 2026 outlook ahead of investor meetings. The investor presentation highlighted strong Q1 2026 normalized FFO, reaffirming its quarterly dividend and emphasizing the senior housing operating portfolio as the largest contributor to segment NOI. The article also details recent insider trading activities, institutional holdings changes, congressional stock trades, and analyst price targets for VTR.
2026-06-05 20:25:35
Ventas, Inc. director Michael J. Embler reported an open-market purchase of 2,500 shares of the company’s Common Stock at an average price of $78.81 per share. This transaction increases his direct ownership to 19,201.958 Ventas shares. The filing, categorized as a moderate impact and positive sentiment, reflects a net-buy insider action.
2026-06-05 08:25:53
CIBC World Market Inc. increased its stake in Ventas, Inc. (NYSE:VTR) by 23% in the fourth quarter, now holding 331,927 shares valued at $25.69 million. Ventas reported Q4 earnings of $0.11 per share, missing estimates by a penny, but revenue reached $1.65 billion, exceeding expectations and up 22% year-over-year. The company declared a quarterly dividend of $0.52 per share and analysts maintain a "Moderate Buy" rating with an average price target of $95.19.
2026-06-05 08:25:53
Daiwa Securities Group Inc. significantly increased its stake in Ventas, Inc. (NYSE: VTR) during the fourth quarter, purchasing an additional 3.08 million shares, bringing its total holdings to $364.12 million. Analysts largely maintain a "Moderate Buy" rating for Ventas, with an average price target of $95.19, despite the company reporting mixed quarterly results with an EPS miss but a revenue beat. Ventas also declared a quarterly dividend of $0.52 per share.
2026-06-04 20:26:38
Welltower Inc. (WELL), a large-cap healthcare REIT, has underperformed the S&P 500 year-to-date and over the past three months, despite a strong 31.3% growth over the past year. The company, valued at $140.9 billion, specializes in healthcare infrastructure and uses a proprietary data science platform to optimize operations. Analysts remain optimistic, giving WELL a "Strong Buy" rating with a target price suggesting a 19% premium.
2026-06-04 20:26:00
Welltower Inc. (WELL), a large-cap healthcare REIT, is valued at $140.9 billion and specializes in real estate for aging populations, leveraging a data science and machine learning platform. Despite recent short-term underperformance against the S&P 500, with its shares down 3.5% over three months compared to the S&P 500's 10.6% gain, it has outperformed over the past 52 weeks and analysts maintain a "Strong Buy" rating with a target price suggesting a 19% premium. The company reported strong Q1 2026 results, with normalized FFO up 23% and revenue up 38.3%.
